Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Alcohol Clin Exp Res ; 33(2): 300-6, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19032578

RESUMO

BACKGROUND: The effects of fetal alcohol exposure on the risks of neonatal lung injury and infection remain under investigation. The resident alveolar macrophage (AM) is the first line of immune defense against pulmonary infections. In utero ethanol (ETOH) exposure deranges the function of both premature and term guinea pig AM. We hypothesized that fetal ETOH exposure would increase the risk of pulmonary infection in vivo. METHODS: We developed a novel in vivo model of group B Streptococcus (GBS) pneumonia using our established guinea pig model of fetal ETOH exposure. Timed-pregnant guinea pigs were pair fed +/-ETOH and some were supplemented with the glutathione (GSH) precursor S-adenosyl-methionine (SAM-e). Term pups were given GBS intratracheally while some were pretreated with inhaled GSH prior to the experimental GBS. Neonatal lung and whole blood were evaluated for GBS while isolated AM were evaluated using fluorescent microscopy for GBS phagocytosis. RESULTS: Ethanol-exposed pups demonstrated increased lung infection and sepsis while AM phagocytosis of GBS was deficient compared with control. When SAM-e was added to the maternal diet containing ETOH, neonatal lung and systemic infection from GBS was attenuated and AM phagocytosis was improved. Inhaled GSH therapy prior to GBS similarly protected the ETOH-exposed pup from lung and systemic infection. CONCLUSIONS: In utero ETOH exposure impaired the neonatal lung's defense against experimental GBS, while maintaining GSH availability protected the ETOH-exposed lung. This study suggested that fetal alcohol exposure deranges the neonatal lung's defense against bacterial infection, and support further investigations into the potential therapeutic role for exogenous GSH to augment neonatal AM function.


Assuntos
Depressores do Sistema Nervoso Central/toxicidade , Etanol/toxicidade , Pneumonia Bacteriana/imunologia , Infecções Estreptocócicas/imunologia , Streptococcus agalactiae , Animais , Animais Recém-Nascidos , Antídotos/farmacocinética , Antídotos/farmacologia , Peso Corporal/efeitos dos fármacos , Depressores do Sistema Nervoso Central/antagonistas & inibidores , Etanol/antagonistas & inibidores , Feminino , Glutationa/farmacocinética , Glutationa/farmacologia , Cobaias , Pulmão/patologia , Macrófagos Alveolares/efeitos dos fármacos , Macrófagos Alveolares/imunologia , Microscopia Confocal , Fagocitose/efeitos dos fármacos , Pneumonia Bacteriana/patologia , Gravidez , Testes de Função Respiratória , S-Adenosilmetionina/administração & dosagem , S-Adenosilmetionina/farmacologia , Sepse/microbiologia , Infecções Estreptocócicas/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA